Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pre-extubation Bupivacaine for Postoperative Pain in Orthognathic Surgery
NCT07518225Completed
- Start
- Sep 2022
- Primary completion
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of bupivacaine in postoperative pain (2 arms). Primary endpoints: Postoperative Pain Intensity at 48 hours and Total and Rescue Morphine Consumption at 24 hours. Started Sep 2022; status: completed.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT07518225.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07518225.